Epidermolysis bullosa, junctional 5A, intermediate: genes and variants
Explore variant evidence for Epidermolysis bullosa, junctional 5A, intermediate across 1 analyzed protein (ITGB4). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 211 variants of uncertain significance and 39 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Epidermolysis bullosa, junctional 5A, intermediate
ITGB4: Integrin beta-4
It pairs with alpha6 integrin in hemidesmosomes to anchor epithelial cells to laminin-rich basement membranes. Biallelic loss-of-function variants can cause junctional epidermolysis bullosa with pyloric atresia and severe epithelial fragility.
5 ClinVar pathogenic / likely pathogenic and 250 uncertain variants in ITGB4 have source records linked to Epidermolysis bullosa, junctional 5A, intermediate. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Epidermolysis bullosa, junctional 5A, intermediate
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ITGB4 C61Y | 61 | PSI | Pathogenic / likely pathogenic (★★) |
| ITGB4 R252C | 252 | VWFA | Pathogenic / likely pathogenic (★★) |
| ITGB4 Y333D | 333 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ITGB4 R1281W | 1281 | Fibronectin type-III 2 | Pathogenic / likely pathogenic (★★) |
| ITGB4 G931D | 931 | Cytoplasmic | Pathogenic / likely pathogenic |
Same protein, different disease
- Junctional epidermolysis bullosa - pyloric atresia also has ClinVar records linked to ITGB4 variants; they fall mostly in different places as the Epidermolysis bullosa, junctional 5A, intermediate variants (13 pathogenic / likely pathogenic).
Diseases related to Epidermolysis bullosa, junctional 5A, intermediate
- Junctional epidermolysis bullosa - pyloric atresia, also linked to ITGB4
- Fetal anomalies with a likely genetic cause, also linked to ITGB4
- Junctional epidermolysis bullosa, also linked to ITGB4
- Junctional epidermolysis bullosa, non-Herlitz, also linked to ITGB4
Frequently asked questions
Which genes have records linked to Epidermolysis bullosa, junctional 5A, intermediate?
This view contains 1 analyzed proteins: ITGB4. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 211 variants of uncertain significance and 39 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 270 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center